A detailed history of Investment Partners, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Investment Partners, Ltd. holds 14,216 shares of BMY stock, worth $827,797. This represents 0.31% of its overall portfolio holdings.

Number of Shares
14,216
Previous 14,493 1.91%
Holding current value
$827,797
Previous $601,000 22.3%
% of portfolio
0.31%
Previous 0.27%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$39.66 - $51.75 $10,985 - $14,334
-277 Reduced 1.91%
14,216 $735,000
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $18,515 - $24,375
-460 Reduced 3.08%
14,493 $601,000
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $3,646 - $4,134
76 Added 0.51%
14,953 $810,000
Q4 2023

Feb 02, 2024

SELL
$48.48 - $57.85 $30,154 - $35,982
-622 Reduced 4.01%
14,877 $763,000
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $70,857 - $79,229
1,224 Added 8.57%
15,499 $899,000
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $29,879 - $33,177
-469 Reduced 3.18%
14,275 $912,000
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $1,839 - $2,086
28 Added 0.19%
14,744 $1.02 Million
Q4 2022

Jan 17, 2023

SELL
$68.48 - $81.09 $1.48 Million - $1.75 Million
-21,566 Reduced 59.44%
14,716 $0
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $2,808 - $1.66 Million
21,603 Added 147.17%
36,282 $2.58 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $1,815 - $1,999
25 Added 0.17%
14,679 $1.13 Million
Q1 2022

Apr 22, 2022

BUY
$61.48 - $73.72 $1,782 - $2,137
29 Added 0.2%
14,654 $1.07 Million
Q4 2021

Feb 04, 2022

BUY
$53.63 - $62.52 $32,178 - $37,512
600 Added 4.28%
14,625 $912,000
Q3 2021

Oct 13, 2021

SELL
$59.17 - $69.31 $4,260 - $4,990
-72 Reduced 0.51%
14,025 $830,000
Q2 2021

Jul 15, 2021

BUY
$61.91 - $67.42 $20,430 - $22,248
330 Added 2.4%
14,097 $942,000
Q1 2021

May 06, 2021

BUY
$59.34 - $66.74 $1,542 - $1,735
26 Added 0.19%
13,767 $869,000
Q4 2020

Jan 19, 2021

BUY
$57.74 - $65.43 $21,652 - $24,536
375 Added 2.81%
13,741 $852,000
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $294,099 - $325,900
-5,121 Reduced 27.7%
13,366 $806,000
Q2 2020

Aug 06, 2020

BUY
$54.82 - $64.09 $2,412 - $2,819
44 Added 0.24%
18,487 $1.09 Million
Q1 2020

Apr 29, 2020

SELL
$46.4 - $67.43 $3,340 - $4,854
-72 Reduced 0.39%
18,443 $1.03 Million
Q4 2019

Jan 31, 2020

SELL
$49.21 - $64.19 $24,408 - $31,838
-496 Reduced 2.61%
18,515 $1.19 Million
Q3 2019

Oct 17, 2019

BUY
$42.77 - $50.71 $17,963 - $21,298
420 Added 2.26%
19,011 $964,000
Q2 2019

Jul 30, 2019

SELL
$44.62 - $49.34 $713 - $789
-16 Reduced 0.09%
18,591 $843,000
Q1 2019

May 03, 2019

SELL
$45.12 - $53.8 $20,529 - $24,479
-455 Reduced 2.39%
18,607 $888,000
Q4 2018

Jan 15, 2019

BUY
$48.76 - $63.23 $2,145 - $2,782
44 Added 0.23%
19,062 $991,000
Q3 2018

Oct 25, 2018

SELL
$55.19 - $62.25 $25,608 - $28,884
-464 Reduced 2.38%
19,018 $62,000
Q2 2018

Jul 25, 2018

SELL
$50.53 - $62.98 $42,394 - $52,840
-839 Reduced 4.13%
19,482 $1.08 Million
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $3,355 - $3,862
56 Added 0.28%
20,321 $1.29 Million
Q4 2017

Jan 31, 2018

BUY
$59.94 - $65.35 $3,776 - $4,117
63 Added 0.31%
20,265 $1.24 Million
Q3 2017

Oct 30, 2017

BUY
$55.23 - $63.74 $1.12 Million - $1.29 Million
20,202
20,202 $1.29 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Investment Partners, Ltd. Portfolio

Follow Investment Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Investment Partners, Ltd. with notifications on news.